Literature DB >> 28734617

Epidemiology, Evolution, and Pathogenesis of H7N9 Influenza Viruses in Five Epidemic Waves since 2013 in China.

Shuo Su1, Min Gu2, Di Liu3, Jie Cui4, George F Gao5, Jiyong Zhou6, Xiufan Liu7.   

Abstract

H7N9 influenza viruses were first isolated in 2013 and continue to cause human infections. H7N9 infections represent an ongoing public health threat that has resulted in 1344 cases with 511 deaths as of April 9, 2017. This highlights the continued threat posed by the current poultry trade and live poultry market system in China. Until now, there have been five H7N9 influenza epidemic waves in China; however, the steep increase in the number of humans infected with H7N9 viruses observed in the fifth wave, beginning in October 2016, the spread into western provinces, and the emergence of highly pathogenic (HP) H7N9 influenza outbreaks in chickens and infection in humans have caused domestic and international concern. In this review, we summarize and compare the different waves of H7N9 regarding their epidemiology, pathogenesis, evolution, and characteristic features, and speculate on factors behind the recent increase in the number of human cases and sudden outbreaks in chickens. The continuous evolution of the virus poses a long-term threat to public health and the poultry industry, and thus it is imperative to strengthen prevention and control strategies.
Copyright © 2017. Published by Elsevier Ltd.

Entities:  

Keywords:  H7N9 influenza virus; evolution; five epidemic waves; highly pathogenic

Mesh:

Substances:

Year:  2017        PMID: 28734617     DOI: 10.1016/j.tim.2017.06.008

Source DB:  PubMed          Journal:  Trends Microbiol        ISSN: 0966-842X            Impact factor:   17.079


  87 in total

1.  Multiple amino acid substitutions involved in the adaption of three avian-origin H7N9 influenza viruses in mice.

Authors:  Jianru Qin; Ouyang Peng; Xiaoting Shen; Lang Gong; Chunyi Xue; Yongchang Cao
Journal:  Virol J       Date:  2019-01-08       Impact factor: 4.099

2.  Structural and Molecular Characterization of the Hemagglutinin from the Fifth-Epidemic-Wave A(H7N9) Influenza Viruses.

Authors:  Hua Yang; Paul J Carney; Jessie C Chang; Zhu Guo; James Stevens
Journal:  J Virol       Date:  2018-07-31       Impact factor: 5.103

3.  Neurovirulence of avian influenza virus is dependent on the interaction of viral NP protein with host factor FMRP in the murine brain.

Authors:  Xuxiao Zhang; Juan Pu; Yipeng Sun; Bi Yuhai; Zhimin Jiang; Guanlong Xu; Hongyu Zhang; Jing Cao; Kin-Chow Chang; Jinhua Liu; Honglei Sun
Journal:  J Virol       Date:  2021-01-06       Impact factor: 5.103

4.  Prevention and treatment of respiratory viral infections: Presentations on antivirals, traditional therapies and host-directed interventions at the 5th ISIRV Antiviral Group conference.

Authors:  Jennifer L McKimm-Breschkin; Shibo Jiang; David S Hui; John H Beigel; Elena A Govorkova; Nelson Lee
Journal:  Antiviral Res       Date:  2017-11-21       Impact factor: 5.970

5.  Avian influenza A (H7N9) virus infections in humans across five epidemics in mainland China, 2013-2017.

Authors:  David S C Hui; Nelson Lee; Paul K S Chan
Journal:  J Thorac Dis       Date:  2017-12       Impact factor: 2.895

6.  Reassortment with dominant chicken H9N2 influenza virus contributed to the fifth H7N9 virus human epidemic.

Authors:  Juan Pu; Yanbo Yin; Jiyu Liu; Xinyu Wang; Yong Zhou; Zejiang Wang; Yipeng Sun; Honglei Sun; Fangtao Li; Jingwei Song; Runkang Qu; Weihua Gao; Dongdong Wang; Zhen Wang; Shijie Yan; Mingyue Chen; Jinfeng Zeng; Zhimin Jiang; Haoran Sun; Yanan Zong; Chenxi Wang; Qi Tong; Yuhai Bi; Yinhua Huang; Xiangjun Du; Kin-Chow Chang; Jinhua Liu
Journal:  J Virol       Date:  2021-03-17       Impact factor: 5.103

7.  Genome Characteristics and Evolution of Pseudorabies Virus Strains in Eastern China from 2017 to 2019.

Authors:  Xiaofeng Zhai; Wen Zhao; Kemang Li; Cheng Zhang; Congcong Wang; Shuo Su; Jiyong Zhou; Jing Lei; Gang Xing; Haifeng Sun; Zhiyu Shi; Jinyan Gu
Journal:  Virol Sin       Date:  2019-07-05       Impact factor: 4.327

8.  Safety and immunogenicity of an 8 year interval heterologous prime-boost influenza A/H7N7-H7N9 vaccination.

Authors:  Hana M El Sahly; Robert L Atmar; Shital M Patel; Abbie Bellamy; Liwei Liu; Wenshan Hong; Huachen Zhu; Yi Guan; Wendy A Keitel
Journal:  Vaccine       Date:  2019-04-04       Impact factor: 3.641

9.  An influenza A virus (H7N9) anti-neuraminidase monoclonal antibody protects mice from morbidity without interfering with the development of protective immunity to subsequent homologous challenge.

Authors:  Jason R Wilson; Jessica A Belser; Juliana DaSilva; Zhu Guo; Xiangjie Sun; Shane Gansebom; Yaohui Bai; Thomas J Stark; Jessie Chang; Paul Carney; Min Z Levine; John Barnes; James Stevens; Taronna R Maines; Terrence M Tumpey; Ian A York
Journal:  Virology       Date:  2017-09-06       Impact factor: 3.616

10.  Efficacy of a Cap-Dependent Endonuclease Inhibitor and Neuraminidase Inhibitors against H7N9 Highly Pathogenic Avian Influenza Virus Causing Severe Viral Pneumonia in Cynomolgus Macaques.

Authors:  Saori Suzuki; Cong Thanh Nguyen; Ayako Ogata-Nakahara; Akihiro Shibata; Hiroyuki Osaka; Hirohito Ishigaki; Masatoshi Okamatsu; Yoshihiro Sakoda; Hiroshi Kida; Kazumasa Ogasawara; Yasushi Itoh
Journal:  Antimicrob Agents Chemother       Date:  2021-02-17       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.